drugset / Trial / NCT01282814
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
RandomizedCrossoverOpen-label
Summary
The objective of this study was to compare the rate and extent of absorption of venlafaxine hydrochloride 150 mg capsules (test) versus Effexor® XR (reference) administered as the content of 1 x 150 mg extended-release capsule mixed with applesauce under fasting conditions.
Timeline
- Start
- 2003-02
- Primary completion
- 2003-03
- Completion
- 2003-03
Outcome
Met primary endpoint
registry Ratio of the T/R geometric mean x 100 115.85 (90% CI 108.45 to 123.72) NCT01282814 ↗
registry Ratio of the T/R geometric mean x 100 109.97 (90% CI 103.68 to 116.63) NCT01282814 ↗
registry Ratio of the T/R geometric mean x 100 106.46 (90% CI 101.45 to 111.71) NCT01282814 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venlafaxine | Small molecule | 150 mg | — |
Indications
No indication recorded.